Publication:
Diagnostic accuracy of nucleic acid amplification-based assays for clostridium perfringens-associated diseases: A systematic review and meta-analysis

dc.contributor.authorKe Chenen_US
dc.contributor.authorSarfraz Ahmeden_US
dc.contributor.authorYun Juan Shengen_US
dc.contributor.authorChangfeng Sunen_US
dc.contributor.authorCun Liang Dengen_US
dc.contributor.authorSuvash Chandra Ojhaen_US
dc.contributor.otherAffiliated Hospital of Luzhou Medical Colleageen_US
dc.contributor.otherUniversity of Veterinary and Animal Sciences Lahoreen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2020-10-05T05:44:26Z
dc.date.available2020-10-05T05:44:26Z
dc.date.issued2020-09-01en_US
dc.description.abstract© 2020 American Society for Microbiology. Timely and accurate methods for detecting Clostridium perfringensassociated diseases (CPAD) are crucial to improve patient care. A number of studies have evaluated the accuracy of nucleic acid amplification tests (NAAT) in detecting CPAD, but decisive results about their effectiveness have not been reported. We conducted a meta-analysis to evaluate the diagnostic performance of NAAT for detecting C. perfringens in clinical diarrheal samples. Five databases including PubMed, Embase, Scopus, Web of Science, and the Cochrane library were systematically probed for studies published before 6 December 2019. From 2,632 citations, we identified five eligible studies comprising 817 samples. Three studies (n =695 samples) compared NAAT with a microbiological culture while the other three studies (n =322 samples) compared NAAT with an immunoassay. NAAT revealed higher diagnostic accuracy against immunoassay (sensitivity, 0.53 [95% confidence interval [CI], 0.35 to 0.7]; specificity, 0.97 [95% CI, 0.95 to 0.99]; positive likelihood ratio [PLR], 23.2 [95% CI, 3.49 to 153.98]; negative likelihood ratio [NLR], 0.25 [95% CI, 0 to 245.28]; diagnostic odds ratio [DOR], 74.11 [95% CI, 2.11 to 2,593.7]) than microbiological culture (sensitivity, 0.31 [95% CI, 0.22 to 0.41]; specificity, 0.95 [95% CI, 0.93 to 0.97]; PLR, 11.56 [95% CI, 3.87 to 34.6]; NLR, 0.57 [95% CI, 0.27 to 1.21]; DOR, 18.1 [95% CI, 4.83 to 67.8]). NAAT pooled specificity was consistently ^ge;95% against that of applied reference standards. A meta-regression and subgroup analysis of sample condition, gene target, study design, and reference standards could not explain the heterogeneity (P > 0.05) in the diagnostic efficiency. The analysis has demonstrated that the diagnostic accuracy of NAAT is relatively insufficient to replace traditional reference standards as a single diagnostic test. NAAT can be applied in combination with microbiological culture because of the advantage of time to result and in scenarios where traditional tests are not feasible. Further investigations in this direction with larger sample sizes are still warranted to support our findings.en_US
dc.identifier.citationJournal of Clinical Microbiology. Vol.58, No.9 (2020)en_US
dc.identifier.doi10.1128/JCM.00363-20en_US
dc.identifier.issn1098660Xen_US
dc.identifier.issn00951137en_US
dc.identifier.other2-s2.0-85089922201en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/59180
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089922201&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleDiagnostic accuracy of nucleic acid amplification-based assays for clostridium perfringens-associated diseases: A systematic review and meta-analysisen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089922201&origin=inwarden_US

Files

Collections